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ABSTRACT 
TAYLOR JOSEPHINE HAYES: Terpenes and flavonoids from Salvia apiana and their binding 
affinities to cannabinoid and opioid receptors 
 
(Under the direction of Dr. Samir Ross)  
 
Salvia apiana (white sage, Lamiacae family) plant is native to southern California and parts of 
Mexico. Some Native American tribes local to this region consider S. apiana to be sacred and 
burn the leaves as incense for purification ceremonies. The plant has been used to treat sore 
throats, coughs, chest colds, upper respiratory infections, and poison oak rashes. Native 
Americans widely used this plant in traditional Chumash healing. Infusion of the leaves is used 
as a diaphoretic and diuretic. The aqueous ethanolic extract of S. apiana showed moderate 
activity towards the CB1 receptor (58.3% displacement). The extract was fractionated on silica 
gel column chromatography using hexanes-acetone gradient to yield 15 fractions. Further 
fractionation using column chromatography led to isolation of nine compounds. The structures of 
the isolated compounds were determined by their 1D, 2D NMR and MS spectral data. They were 
identified to be four diterpenes: rosmadial, carnosol, 16-hydroxycarnosol, and sageone; two 
flavonoids: cirsimaritin, and salvigenin; and three triterpenes: oleanolic acid, uvaol, and ursolic 
acid. All the fractions and isolated compounds were submitted for biological studies for 
cannabinoid and opioid receptor binding. One diterpene, sageone, was found to be active towards 
CB1 (72.5% displacement) and CB2 (79.8% displacement) and moderately active towards the mu 
opioid receptor (54.7% displacement).  
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Background 
 
I. Salvia apiana 
 
Figure 1: Salvia apiana (Weldon, 2010) 
Salvia apiana, a member of the Lamiaceae family, is commonly known as white 
sage. The shrub has long, thin, velvety leaves and colors ranging from shades of gray to 
green. Small flowers grow on white sage that can be purple or white with long anthers 
(Adams and Garcia, 2005). S. apiana can be found scattered throughout southwestern 
North America, with the highest concentration in Southern California (Borek et al., 
2006).  
Natives to the southern California region have been known to use the leaves in 
traditional Chumash healing. Chumash healing involves prayer, relaxation, and natural 
plant-based remedies. In this practice, white sage is infused into water in order to relax 
the patient (Adams and Garcia, 2005). The leaves have been smoked and eaten to treat 
sore throats, upper respiratory infections, coughs, colds, and even poison oak rashes 
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(Takeoka et al., 2008). The plant is also administered for diaphoretic and diuretic effects 
(Luis et al., 1996). The leaves are thought to be sacred by some native tribes and burned 
during purification ceremonies, or simply for the aroma (Dentali and Hoffman, 1990).   
 
Figure 2: Salvia apiana smoking (Moving Towards Peace, 2010) 
 
II. Receptors 
 Cannabinoid and Opioid receptors are classified as G-protein coupled receptors, 
which are signaling receptors that recognize and transduce messages across cell 
membranes (Boackaert and Pin, 1999). The main subtypes of cannabinoid receptors are 
the CB1 and CB2 receptors, and the most prominent opioid receptors are mu (µ), kappa 
(κ), and delta (δ). In humans, the CB1 receptor is found throughout the central nervous 
system in the brain and spinal cord, while the CB2 receptor is more abundant in the 
peripheral nervous system throughout the body (Reisine and Brownstein, 1994). These 
receptors control a wide range of processes in the body including memory, appetite, and 
pain sensing. Opioid receptors are very important in the central nervous system, 
cardiovascular, immune, reproductive, endocrine, and digestive systems (Reisine and 
Brownstein, 1994). They regulate various physiological functions, most prominently 
neurohormonal secretion in the adrenal and pituitary glands (Kapas et al., 1995). 
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III. Medicinal Uses 
 Dentali and Hoffman (1992) found that S. apiana has anti-infective activity, and 
was able to inhibit all four bacteria species tested. Mazzio and Soliman (2009) identified 
that the species exhibits anti-inflammatory, antioxidant, antimalarial, and antifungal 
capabilities. They also found that S. apiana can help improve cognitive function, mood, 
and alertness. Numerous studies have also been conducted to investigate compounds 
found in S. apiana that can be useful in essential oils (Borek et al., 2006; Ali et al., 2015).  
 
IV. Previous Chemical Study 
 Previous to our research, some phytochemical studies had been reported. Pettit et 
al. (1966) reported the identification of triterpenes α-amyrin, oleanolic acid, and ursolic 
acid in S. apiana. Dentali and Hoffman (1990) reported the isolation of the terpenes 16-
hydroxycarnosic acid, carnosic, and salvin. Gonzalez et al. (1992) reported many 
terpenes isolated from S. apiana. These terpenes are: 6,7-didehydroferruginol, 6,7-
didehydrosempervirol, 16-hydroxy-6,7-didehydroferruginol, 11,12,16-trihydroxy-
20(10à5)abeo-abieta-1(10),6,8,11,13-pentaene, quinones, 16-hydroxyroyleanone, and 6-
deoxo-5,6-didehydrolanugon Q, ferruginol, miltiodiol, cryptotanshinone, lanugon Q and 
salvicanol. Luis et al. (1996) reported the isolation of many terpenes: 16-
hydroxycarnosol, 16-hydroxyrosmanol, 16-hydroxy-7-methoxyrosmanol, rosmanol, 7-
epirosmanol, and savicanol. Luis et al. (1996) reported the identification of many 
terpenes from S. apiana. These terpenes are 14-hydorxy-7-methoxy-11,16-diketo-apian-
8-en-(22,6)-olide, 7-methoxy-11,16-diketo-apian-8,14-dien-(22,6)-olide, 16-
hydroxycarnosic acid, hassanane and apianane. Borek et al. (2006) reported the 
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identification of terpenes from S. apiana. These terpenes are: α-thujene, α-pinene, 
camphene, β-pinene, myrcene, δ-3-carene, cymene, limonene, 1,8-cineole, α-pinene 
oxide, camphor, and terpinolenone. Abreu et al. (2008) reported the identification of the 
terpenes α-tocophenol, carnosol and carnosic acid. Takeoka et al. (2010) reported the 
identification of the terpene terpinolene.  
 
V. Objective 
Based on the native uses for S. apiana and previous research, we are interested in 
isolating compounds that could have a significant effect on CB1 and CB2 cannabinoid 
receptors and µ, δ, and κ opioid receptors. Although the chemical make up of S. apiana 
has been studied, it has yet to be studied specifically for neurological activity.  
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Methods 
 
I. Purchase and Extraction 
 The S. apiana plant material was purchased from River’s Source Botanicals in 
Taos, New Mexico. 900g of the plant material were macerated with 190 proof ethanol 
three times. The extract was filtered and evaporated to yield 171.8g of crude extract.  
	  
Figure 3: Plant material being filtered after an ethanolic extraction (Kratom & Kratom 
Extracts, 2015) 
 
II. Isolation 
 160 g of the S. apiana extract were loaded onto a column with 2400g of silica gel. 
The column was eluted with 100% hexanes (1000mL), followed by 1000mL of 2%, 4%, 
6%, 8%, 10%, 15%, 20%, 25%, 30%, 40%, 60%, 80%, 100% acetone-hexanes, and 
finally washed with 100% methanol. Fifteen fractions were obtained from this column. 
These fifteen fractions were submitted for CB1 and CB2 bioassay. Table 8 (Page 37) 
shows the bioassay results for these fractions. 
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Figure 4: Two normal phase columns 
 We began the isolation process by performing column chromatography on select 
fractions. The fractions with higher CB1 and CB2 activities were favored. Fractions 8, 9, 
10, and 13 were found to be active. We tested samples from the fractions by TLC. The 
solvent systems tested were typically mixtures of acetone-hexane, EtOAc-hexane, and 
Methanol-DCM. Based on TLC, we chose the solvent gradient to purify each fraction. 
Once a fraction and solvent system were selected, the material was loaded on to a column 
packed with silica gel. Solvent was run through the column using a gradient (low polar to 
high polar). The fractions from the chromatography were tested with TLC. Based on the 
TLC results, we were able to divide the material into fractions of similar content. From 
these fractions, we were able to repeat the process until a single compound was isolated. 
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Figure 5: A fraction being evaporated with a rotavapor 
 From fraction 9 (active), diterpene sageone (IV) was isolated. From the fraction 
11 (inactive), two terpenes rosmadial (I) and uvaol (VIII) were isolated. From fraction 13 
(active), two terpenes, carnosol (II) and oleanolic acid (VII), and one flavonoid, 
salvigenin (VI), were isolated. From fraction 14, two terpenes, 16-hydroxycarnosol (III) 
and ursolic acid (IX), and one flavonoid, cirsimaritin (V), were isolated. Figure 6 shows 
the flow chart for isolation of compounds (I-IX).  
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Figure 6: Flow chart of isolated compounds 
 
III. Structure Elucidation 
 We were able to elucidate the molecular structure of each isolated compound 
using NMR and mass spectra. A Bruker model AMX 500 NMR spectrometer operating 
on a standard pulse system collected 1H and 13C NMR spectra. The instrument ran at 400 
MHz in 1H and 125 to 100 MHz in 13C. CDCl3 and DMSO were used as solvents, and 
TMS was used as an internal standard. HRMS were obtained on a Micromas Q-Tof 
Micro mass spectrometer. All nine isolated compounds were known and their spectral 
data were compared with previously reported data.  
 
IV. Bioassay 
All the fractions and isolated compounds were submitted for biological studies in 
CB1, CB2, and opioid assays.  To prepare the membrane for bioassay, HEK293 cells were 
transfected with plasmids containing cloned human CB1 and CB2 receptors. They were 
Ethanolic extract of S. apiana
2 5 643 10987 11 12 14131 15
I
IV
V
VIII
III
VII
VIII
IX
Column chromatography using 
Hexanes-acetone gradient
Column chromatography using 
Hexane- EtOAc gradient
Column chromatography using 
Hexane- EtOAc gradient
Column chromatography using 
Hexane- EtOAc gradient
Column chromatography using 
Hexane- EtOAc gradient
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held at 37°C and 5% CO2 in a DMEM mixture F-12 HAM with 2 mM L-glutamine, 10% 
fetal bovine system, 1000 IU/mL penicillin, 1000 µg/mL of streptomycin, and 0.5 mg/mL 
G418 antibiotic solution. Other HEK293 cells were transfected with δ, κ, and µ receptors 
the same way.  The cells were scraped in cold Tris-HCl, (pH 7.4) and centrifuged at 
5200g for 10 minutes at 4°C to prepare the membrane. The pellet was resusupended in 
the buffer while the supernatant was disposed of. The pellet was homogenized with a 
sonic dismembrator model 100 for 30 seconds and centrifuges at 1000g for 10 minutes. 
This process was repeated two more times, saving the supernatant. The supernatants were 
combined and centrifuged at 23300g for 40 minutes at 4°C. The pellet was resuspended 
and dispersed into 2 mL vials to be stored at -80°C. Each bath was tested with membrane 
evaluation and saturation binding experiments to obtain optimal membrane and 
radioligand concentrations.  
 After the membrane was prepared, the compounds were evaluated in competition 
binding with both CB1 and CB2. The screening was performed with 10 µM of each 
compound from independent triplicate dilutions incubated with 1.6975 nM of CB1or 
1.959 nM of CB2.  [3H]-CP 55,940 and 5 µg of CB1 or 1 µg of CB2 membrane were 
incubated at 37°C for 90 minutes with gentle agitation in a 96 well plate in a 0.2 mL final 
volume of 50 mM Tris-HCl, 20 mM EDTA, 154 mM NaCl (pH 7.4) buffer with 0.2% 
BSA. 25 µL of MicroScint20 was added after the filters were dried, and plates were read 
with TopCount NXT microplate scintillation counter. Total binding referred to binding in 
the presence of a vehicle (1.0% DMSO), while nonspecific binding referred to binding 
observed in the presence of 10.0 µM CP-55,940. Specific binding was the difference 
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between nonspecific and total binding observed. The following formula was used to 
calculate percent displacement: 
 100 – (binding of compound – nonspecific binding) x 100/ specific binding 
Compounds were also tested with competition binding assays for opioid receptors 
δ, κ, and µ. Independent triplicate dilutions of 10µM of the compound were incubated 
with 0.85 [3H]-DAMGO (µ), 0.91 nM [phenyl-3,4-3H]-U-69,593 (κ) or 0.99 nM [3H]-
DPDPE (δ) for 60 minutes in a 96-well plate in 0.2 mL final volume of 50 mM Tris-HCl 
(pH 7.4) with 15µg (κ) or 20µg (µ and κ) of membrane.  Rapid vacuum was used to 
terminate the reaction with a Unifilter 96 GF/B filter that was presoaked with 0.3% BSA 
and washed 10 times with 4°C 50 mM Tris-HCl (pH 7.4). 50µL of MicroScint20 was 
added after the filter dried and plates were read with a TopCount NXT microplate 
scintillation counter. Total binding was calculated by the following formula: 
 100 – (Binding of compound – nonspecific binding) x 100/ specific binding 
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Isolated Compounds 
 
Compound I: Rosmadial  
Compound I, identified as diterpene rosmadial, was obtained as colorless oil (17.0 
mg). The HRESIMS spectrum of I showed a molecular ion [M-H]- peak at m/z 343.1652 
(figure 9), compatible with molecular formula C20H24O5 (calculated value is 343.1546). 
The 1H NMR and 13C NMR data for compound I (see table 1) match with the data for 
rosmadial (Nakatani and Inatani, 1983). This was the first reporting of rosmadial from 
this plant, and it has been previously isolated from Rosemarinus officinalis (Nakatani and 
Inatani, 1983) and Salvia miltiorrhiza (Haro et al., 1991).  
 
Table 1: 1H NMR and 13C NMR data for rosmadial 
Carbon  1H NMR 13C NMR (DEPT) 13C NMR (Nakatani and 
Inatani, 1983) 
1 2.29 (td, 13.6, 3.8); 
1.72 (dd, 13.6, 3.8) 
31.71 (t) 31.5 
2 2.11 (qt, 13.4, 2.8) 16.78 (t) 16.5 
3 1.92 (td, 13.4, 2.3); 
1.62 (dt 15.3, 3.2) 
40.39 (t) 40.1 
4 - 34.18 (s) 33.9 
5 4.12 (s) 61.32 (d) 61.1 
6  9.68 (s) 202.39 (d) 201.9 
7 9.79 (s) 192.30 (d) 191.9 
 12 
Carbon  1H NMR 13C NMR (DEPT) 13C NMR (Nakatanie and 
Inatani, 1983) 
8 - 124.03 (s) 123.9 
9 - 131.92 (s) 135.9 
10 - 48.49 (s) 48.3 
11 - 141.40 (s) 142.5 
12 - 143.06 (s) 141.0 
13 - 136.24 (s) 131.6 
14 7.42 (s) 131.47 (d) 131.1 
15 3.34 (sept. 6.8) 27.15 (d) 26.9 
16 1.29 (d, 6.2) 22.43 (q) 22.0 
17 1.29 (d, 6.2) 22.27 (q) 22.1 
18 1.52 (s) 33.47 (q) 33.2 
19  1.30 (s) 24.02 (q) 23.7 
20 - 177.50 (s) 176.9 
 
 
 
Figure 7: 1H NMR results for rosmadial 
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Figure 8: 13C NMR spectrum for rosmadial 
 
 
 
 
Figure 9: HRMS for rosmadial  
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Figure 10: Chemical structure of rosmadial (I) 
 
Compound II: Carnosol 
Compound II, identified as diterpene carnosol, was obtained as a white solid 
(23.5 mg). The HRESIMS spectrum of II showed a molecular ion [M-H]- peak at m/z 
329.1672 (figure 13), compatible with molecular formula C20H26O4 (calculated value is 
329.1753). The 1H NMR and 13C NMR data for compound II (see table 2) match with the 
published data for diterpene carnosol, which has been previously isolated from S. apiana 
(Abreau et al., 2008).   
 
Table 2: 1H NMR and 13C NMR data for carnosol 
Carbon  1H NMR 13C NMR (DEPT) 13C NMR (Inatani et al., 
1982) 
1 - 29.10 (t) 29.8 
2 - 18.84 (t) 19.7 
3  - 40.81 (t) 41.9 
4 - 34.45 (s) 35.1 
5 - 45.31 (d) 46.1 
O
O
OH
O
O
H
H
2
4 6
810
11 13
14
15
16
17
18 19
20
 15 
Carbon  1H NMR 13C NMR (DEPT) 13C NMR (Inatani et al., 
1982) 
6  - 29.53 (t) 30.6 
7 5.43 (brd, 2.9) 77.39 (d) 78.2 
8 - 131.92 (s) 133.6 
9 - 122.11 (s) 123.1 
10 - 48.21 (s) 49.2 
11 - 143.54 (s) 143.8 
12 - 143.27 (s) 143.4 
13 - 134.71 (s) 135.1 
14 6.68 (s) 111.67 (s) 112.4 
15  - 26.51 (d) 27.6 
16 1.12 (d, 7.2) 22.95 (q) 23.0 
17 - 23.11 (q) 23.1 
18 0.80 (s) 31.65 (q) 32.0 
19  0.77 (s)  19.70 (q) 20.0 
20 - 176.13 (s) 175.9 
 
 
Figure 11: 1H NMR results for carnosol 
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Figure 12: 13C NMR spectrum for carnosol 
 
 
 
Figure 13: HRMS for carnosol  
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Figure 14: Chemical structure of carnosol (II) 
 
Compound III: 16-hydroxycarnosol 
Compound III, identified as diterpene 16-hydroxycarnosol, was obtained as 
colorless crystals (25.0 mg). The HRESIMS spectrum of III showed a molecular ion [M-
H]- peak at m/z 345.1806 (figure 17), compatible with molecular formula C20H26O5 
(calculated value is 345.1702). The 1H NMR and 13C NMR data for compound III (see 
table 3) match with the data for carnosol, which has been previously isolated from S. 
apiana (Luis et al., 1996). 
 
Table 3: 1H NMR and 13C NMR data for 16-hydroxycarnosol 
Carbon  1H NMR 13C NMR (DEPT) 13C NMR (Luis et al., 1993) 
1 - 28.89 (t) 29.17 
2 - 18.99 (t) 19.26 
3  - 41.21  (t) 41.49 
4 - 34.63 (s) 34.90 
5 - 45.60 (d) 45.87 
6  - 29.87 (t) 30.15 
7  5.44 (dd, 1.0, 3.7) 77.96 (d) 78.15 
8 - 132.24 (s) 132.69 
O
O
HO
OH
1
4 6
9
10
11 13
15
16
17
18 19
20
14
 18 
Carbon  1H NMR 13C NMR (DEPT) 13C NMR (Luis et al., 1993) 
9 - - 122.25 
10 - 48.51 (s) 48.77 
11 - 143.74 (s) 144.01 
12 - 143.05(s) 143.26 
13 - 129.19 (s) 129.38 
14 6.64 (s) 113.13 (d) 113.35 
15  - 37.70 (d) 37.87 
16 3.48 (m) 70.06 (t) 70.48 
17 1.15 (d, 6.8) 15.24 (q) 15.48 
18  0.78 (s) 19.81 (q) 20.08 
19  0.81 (s)  31.87 (q) 32.14 
20 - 210.19 (s) 176.67 
 
 
 
 
Figure 15: 1H NMR results for 16-hydroxycarnosol 
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Figure 16: 13C NMR spectrum for 16-hydroxycarnosol 
 
 
 
Figure 17: HRMS for 16-hydroxycarnosol  
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Figure 18: Chemical structure of 16-hydroxycarnosol (III) 
 
Compound IV: Sageone 
Compound IV, identified as diterpene sageone, was obtained as colorless crystals 
(42.5 mg). The HRESIMS spectrum of IV showed a molecular ion [M+H]+ peak at m/z 
301.1867 (figure 21), compatible with molecular formula C19H24O3 (calculated value is 
301.1804). The 1H NMR and 13C NMR data for compound IV (see table 4) match with 
the data for sageone (Tada et al., 1994). This was the first reporting of sageone from S. 
apiana, and it has been previously isolated from Salvia officinalis (Tada et al., 1994). 
 
Table 4: 1H NMR and 13C NMR data for sageone 
Carbon 1H NMR 13C NMR (DEPT) 13C NMR (Tada et al., 1994) 
1 - 202.12 (s) 202.1 
2 2.67 (t, 6.8) 35.19 (t) 35.1 
3  1.92 (t, 6.8) 35.76 (t) 35.6 
4 - 37.28 (s) 37.2 
5 - 175.67 (s) 175.8 
6  2.52 (dd, 6.8, 8.3) 27.50 (t) 27.4 
7 2.37 (dd, 6.8, 8.3) 28.52 (t) 28.4 
8 - 127.58 (s) 127.5 
9 - 130.40 (s) 130.3 
OH
O
O
H
1
3
5
810
11 13
14
15OH
HO
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Carbon  1H NMR 13C NMR (DEPT) 13C NMR (Tada et al., 1994) 
10 - 116.62 (s) 116.5 
11 - 140.09 (s) 139.9 
12 - 143.41 (s) 143.2 
13 - 133.16 (s) 133.1 
14 6.58 (s) 116.62 (d) 116.5 
15  3.29 (sept, 6.9) 27.31 (d) 27.1 
16 1.23 (d, 6.9) 22.47 (q) 22.4 
17 1.23 (d, 6.9) 22.47 (q) 22.4 
18  1.26 (s) 26.22 (q) 26.1 
19  1.26 (s)  26.22 (q) 26.1 
 
 
 
 
 
 
Figure 19: 1H NMR results for sageone 
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Figure 20: 13C NMR spectrum for sageone 
 
 
 
Figure 21: HRMS for sageone 
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Figure 22: Chemical structure of sageone (IV) 
 
Compound V: Cirsimaritin  
Compound V, identified as flavone cirsimaritin, was obtained as a yellow solid 
(20.4 mg). The HRESIMS spectrum of V showed a molecular ion [M-H]- peak at m/z 
313.0852 (figure 25), compatible with molecular formula C17H22O6 (calculated value is 
321.1338). The 1H NMR and 13C NMR data for compound V (see table 5) match with the 
data for cirsimaritin (Wang et al., 2004). This was the first reporting of cirsimaritin from 
this plant, and it has been previously isolated from Trollius chinensis (Wang et al., 2004). 
 
Table 5: 1H NMR and 13C NMR data for cirsimaritin  
Carbon  1H NMR 13C NMR (DEPT) 13C NMR (Wang et al., 2004) 
2 - 163.99 (s) 164.0 
3  6.85 (s) 102.72 (d) 102.6 
4 - 182.83 (s) 182.2 
4a - 105.09 (s) 105.0 
5 - 152.01 (s) 152.1 
6  - 131.79 (s) 131.8 
7  - 158.51 (s) 158.6  
O
OH
HO
1
3 5
8
9
10
11 13
14
15
16
17
18 19
 24 
Carbon  1H NMR 13C NMR (DEPT) 13C NMR (Wang et al., 2004) 
8 6.94 (s) 91.58 (d) 91.5 
8a - 152.54 (s) 152.6 
1’ - 121.00 (s) 121.1 
2’ 7.96 (d, 8.8 Hz) 128.57 (d) 128.5 
3’ 6.95 (d, 8.8 Hz) 115.89 (d) 115.9 
4’ - 161.24 (s) 161.3 
5’ 6.95 (d, 8.8 Hz) 115.89 (d) 115.9 
6’  7.96 (d, 8.8 Hz) 128.57 (d) 128.5 
6-OMe 3.73 (s) 59.93 (q) 60.0 
7-OMe 3.93 (s) 56.34 (q) 56.4 
 
 
 
 
 
Figure 23: 1H NMR results for cirsimaritin 
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Figure 24: 13C NMR spectrum for cirsimaritin 
 
 
 
Figure 25: HRMS for cirsimaritin  
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Figure 26: Chemical structure of cirsimaritin (V) 
 
Compound VI: Salvigenin 
Compound VI, identified as flavone salvigenin, was obtained as a yellow solid 
(70.6 mg). The HRESIMS spectrum of VI showed a molecular ion [M+H]+ peak at m/z 
329.1334 (figure 29), compatible with molecular formula C18H16O6 (calculated value is 
329.1025). The 1H NMR and 13C NMR data for compound VI (see table 6) match with 
the data for salvigenin (Ayatollahi et al., 2009). This was the first isolation of salvigenin 
from this plant, and it has been previously isolated from Salvia leriaefolia (Ayatollahi et 
al., 2009) and Amomum koenigii (Dong et al., 1999).  
 
 
Table 6: 1H NMR and 13C NMR data for salvigenin  
Carbon  1H NMR 13C NMR (DEPT) 13C NMR (Ayatollahi et al., 2009) 
2 - 164.07 (s) 163.9 
3 6.54 (d, 4.7) 104.13 (d) 104.0 
4  - 182.73 (s) 182.6 
4a - 106.19 (s) 106.4 
5 - 153.11 (s) 153.1 
6  - 132.67 (s)  132.5 
7  - 158.80 (s) 158.7 
8 6.51 (d, 3.3) 90.66 (d)  90.5  
O
OOH
MeO
MeO
OH
2
44a
8
6
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5'
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Carbon  1H NMR 13C NMR (DEPT) 13C NMR (Ayatollahi et al., 2009) 
8a - 153.28 (s) 153.0 
1’ - 123.54 (s) 123.4 
2’ 7.80 (m) 128.06 (d) 127.9 
3’ 6.98 (m) 114.60 (d) 114.4 
4’ - 162.69 (s) 162.6 
5’ 6.98 (m) 114.59 (d) 114.4 
6’  7.80 (m) 128.06 (d) 127.9 
6-OMe 3.91 (s) 60.95 (q) 60.8 
7-OMe  3.95 (s) 56.41 (q) 56.2 
4’-OMe 3.88, (s)  55.64 (q) 55.5 
 
 
 
 
Figure 27: 1H NMR results for salvigenin 
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Figure 28: 13C NMR spectrum for salvigenin 
 
 
 
Figure 29: HRMS for salvigenin  
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Figure 30: Chemical structure of Salvigenin (VI) 
 
Compound VII: Oleanolic Acid  
Compound VII, identified as triterpene oleanolic acid, was obtained as a white 
solid (15.0 mg). The HRESIMS spectrum of VII showed a molecular ion [M-H]- peak at 
m/z 455.3348 (figure 33), compatible with molecular formula C30H48O3 (calculated value 
is 455.3525). The 1H NMR and 13C NMR data for compound VII (see table 7) match 
with the data for oleanolic acid (Pettit et al., 1966). This compound has been previously 
isolated from S. apiana (Pettit et al., 1966).  
 
Figure 31: 1H NMR results for oleanolic acid 
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Figure 32: 13C NMR spectrum for oleanolic acid 
 
 
 
Figure 33: HRMS for oleanolic acid  
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Figure 34: Chemical structure of oleanolic acid (VII) 
 
Compound VIII: Uvaol 
Compound VIII, identified as triterpene uvaol, was obtained as a white solid (5.5 
mg). The HRESIMS data was compatible with molecular formula C30H50O2 (calculated 
value is 442.3811). The 1H NMR and 13C NMR data for compound VIII (see table 8) 
match with the data for uvaol (Lee et al., 2013). This compound has been previously 
isolated from Ilex cornuta (Lee et al., 2013), and this was the first time isolated from S. 
apiana. 
 
Table 7: 1H NMR and 13C NMR and data for uvaol 
Carbon  1H NMR 13C NMR (DEPT) 13C NMR (Lee et al., 2013) 
1 - 38.89 (t) 38.0 
2 - 26.12 (t) 26.0 
3 3.21 (dd, 4.7, 10.5) 79.15 (d) 79.0 
4 - 38.89 (s) 38.7 
5 - 55.29 (d) 55.2 
6 - 18.45 (t) 18.3 
7  - 32.94 (t) 32.8 
OH
HO
O
1
4 6
9
10
11 13
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17
19
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28
27
2625
24
H
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Carbon  1H NMR 13C NMR (DEPT) 13C NMR (Lee et al., 2013) 
8 - 40.13 (s) 40.0 
9 - 38.11 (s) 47.6 
10 - 36.99 (s) 36.9 
11 - 23.44 (t) 23.3 
12 5.125 (t, 3.6) 125.14 (d) 125.0 
13 - 138.83 (s) 138.7 
14 - 42.16 (s) 42.0 
15  - 27.33 (t) 27.2 
16 - 23.51 (t) 23.4 
17 - 47.78 (d) 47.7 
18  - 54.15 (d) 54.0 
19  - 39.47 (d) 39.3 
20 - 39.54 (d) 39.4 
21 - 30.75 (t) 30.6 
22 - 35.31 (t) 35.2 
23 0.98 (s) 28.25 (q) 28.1 
24 0.96 (s) 15.82 (q) 15.7 
25 0.92 (d) 15.76 (q) 15.6 
26 - 16.89 (q) 16.7 
27 1.09 (s) 23.44 (q) 23.2 
28 3.51 (d, 10.6); 3.17 
(d, 10.6) 
70.01 (t) 69.9 
29 0.79 (d, 6.1) 17.48 (q) 17.3 
30 0.78 (d, 6.1) 21.46 (q) 21.3 
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Figure 35: 1H NMR results for uvaol 
 
 
 
Figure 36: 13C NMR spectrum for uvaol 
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Figure 37: Chemical structure of uvaol (VIII) 
 
Compound IX: Ursolic Acid 
Compound IX, identified as triterpene ursolic acid, was obtained as a white solid 
(5.2 mg). The HRESIMS spectrum of IX was compatible with molecular formula 
C30H48O3 (calculated value is 456.3603). The 1H NMR and 13C NMR data for compound 
IX match with the data for ursolic acid (Pettit et al., 1966). This compound has been 
previously isolated from S. apiana (Pettit et al., 1966).  
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Figure 38: 1H NMR results for ursolic acid 
 
Figure 39: 13C NMR spectrum for ursolic acid 
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Figure 40: Chemical structure of ursolic acid (IX) 
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Bioassay Results 
 
I. Original Column Bioassay Results 
 S. apiana extract was fractionated over silica gel column using a hexane-acetone 
gradient. This column yielded fifteen fractions that were used for further isolation. Table 
8 shows the bioassay results for the ethanolic extract of S. apiana and the fifteen original 
fractions. These bioassay results were necessary to (a) determine whether S. apiana has 
good enough potential for active compounds and (b) guide our isolation process by 
indicating which fractions are the most active and therefore most likely to contain active 
compounds.  
The crude extract shows 58.3% displacement at the CB1 receptor, indicating 
moderate activity.  This shows that S. apiana has high potential for isolation of active 
compounds.  
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Table 8: Bioassay results of crude extract and 15 fractions 
Fraction 
% Inhibition (10 µm/mL) 
CB1 CB2 Delta Kappa Mu 
Extract 58.3 22.2 14.7 15.4 10.0 
Fraction 1 - - - - 4.1 
Fraction 2 - 5.3 - - - 
Fraction 3 - 33.0 - 8.7 - 
Fraction 4 - 2.3 2.1 5.3 26.1 
Fraction 5 - 3.4 4.4 - 38.8 
Fraction 6 8.9 - - - 38.0 
Fraction 7 5.5 30.8 3.7 - 31.9 
Fraction 8 12.8 75.0 - 6.0 - 
Fraction 9 22.5 50.1 - - - 
Fraction 10 60.1 72.0 27.3 34.1 52.0 
Fraction 11 23.4 35.9 28.1 17.9 29.0 
Fraction 12 26.5 23.3 16.0 48.5 31.9 
Fraction 13 - 27.3 53.4 23.8 33.1 
Fraction 14 - - 24.5 12.3 30.5 
Fraction 15 11.2 - 11.8 26.1 6.7 
 
 
II. Isolated Compound Bioassay Results  
 The nine isolated compounds were sent for bioassay, which tested their binding 
towards CB1, CB2, δ, κ, and µ receptors. Table 9 shows the results of that bioassay for all 
nine compounds with respect to the five-receptor types in question. For compounds VII, 
VIII, and IX there was a problem with the cell lines that did not allow for accurate CB1 
results. Testing of compounds VII, VIII, and IX is in progress.  
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Compound IV, sageone, shows moderate inhibition of the µ receptor (54.7%) and 
high levels of inhibition of CB1 and CB2 (72.5% and 79.8%). These values indicate that 
sageone is highly active, and is promising for future research. 
Compound VIII, uvaol, shows moderate inhibition of the µ receptor (45.6%). 
uvaol should also be researched further because of this potential for activity. 
 
Table 9: Bioassay results of the nine isolated compounds 
Compound 
% Inhibition (10 µm/mL) 
CB1  CB2 Delta Kappa Mu 
I (Rosmadial) 15.9 12.8 3.6 12.4 0.3 
II (Carnosol) 15.8 14.9 - - 3.9 
III (16-hydroxycarnosol) 30.9 0.5 6.6 21.8 13.6 
IV (Sageone) 72.5 79.8 14.4 36.1 54.7 
V (Cirsimaritin) 22.2 10.0 23.4 10.8 21.2 
VI (Salvigenin) 3.9 - - 0.4 18.1 
VII (Oleanolic Acid) - 6.1 27.3 - 27.7 
VIII (Uvaol) - 13.8 29.9 6.1 45.6 
IX (Ursolic Acid) - - 18.8 17.7 39.4 
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Conclusion 
  
Salvia apiana is a plant found in southern California and Mexico that has many 
traditional uses ranging from purification to treating sore throats, respiratory infections, 
coughs and colds.  The extract showed 58.3% inhibition towards the CB1 receptor, 
indicating high potential for the isolation of active compounds. Bioassay guided 
fractionation was used to isolate nine compounds. 
Of the nine compounds isolated from S. apiana, four are diterpenes, two are 
flavones, and three are triterpenes. The diterpenes were identified as rosmadial, carnosol, 
16-hydrocycarnosol, and sageone. The flavones were identified as cirsimaritin and 
salvigenin. The triterpenes were identified as oleanolic acid, uvaol, and ursolic acid.  
Five of the nine compounds were isolated from S. apiana for the first time. These 
compounds are rosmadial, sageone, cirsimaritin, salvigenin, and uvaol. These findings 
give us insight into the chemical makeup of S. apiana. 
Sageone was found to be active towards CB1, CB2, and µ receptors. Further 
evaluation of sageone is in progress. Uvaol also showed moderate activity (µ) and would 
be worth studying further. 
S. apiana has great potential for further isolation of more active compounds, and 
there is still more to be discovered. Isolation is still in progress, with the hope of isolating 
more active compounds. 
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